{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=38940&ordering=-name","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=38900&ordering=-name","results":[{"accession":"CLO:0009959","name":"CoCM-1 cell","definition":"[]","term_type":"cell line"},{"accession":"EFO:0000359","name":"Cockayne syndrome","definition":"['A simple genetic disease that is caused by a rare autosomal recessive mutations in two DNA excision repair proteins, ERCC-8 and ERCC-6, and characterized by growth failure, impaired development of the nervous system, abnormal sensitivity to sunlight (photosensitivity), and premature aging.', 'A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms.', 'An autosomal recessive syndrome caused by mutations in the ERCC8 and ERCC6 genes. It is characterized by growth and developmental delay, vision and hearing impairment, and impairment of the peripheral nervous system function.', 'Caused by mutations of gene CKN1.', 'Caused by mutations of gene ERCC6.', 'Type C is a rare form. Its genetic defect is not clear; appears to be a heterogeneous group. OMIM suggests that Type C should not be used anymore.']","term_type":"cell line"},{"accession":"DOID:2212","name":"coagulation protein disorder","definition":"[]","term_type":"cell line"},{"accession":"DOID:2232","name":"coagulation factor deficiency","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002540","name":"Co88BV59H21-2V67-66 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002539","name":"Co88BV59H21-2 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002538","name":"CO 88BV59-1 cell","definition":"[]","term_type":"cell line"},{"accession":"CL:0000117","name":"CNS neuron (sensu Vertebrata)","definition":"[]","term_type":"cell line"},{"accession":"CL:0000402","name":"CNS interneuron","definition":"[]","term_type":"cell line"},{"accession":"DOID:641","name":"CNS demyelinating autoimmune disease","definition":"[]","term_type":"cell line"},{"accession":"NCBITaxon:6073","name":"Cnidaria","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002537","name":"CNC 127I cell","definition":"['disease: mammary tumor']","term_type":"cell line"},{"accession":"MS:1001307","name":"CNBr","definition":"Cyanogen bromide.","term_type":"cleavage agent"},{"accession":"CLO:0002536","name":"CN96 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002535","name":"C-N95 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002534","name":"C-N90 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002532","name":"CMT-93 cell","definition":"['disease: polyploid carcinoma']","term_type":"cell line"},{"accession":"CLO:0002530","name":"CMT 93 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002533","name":"CMT93/69 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0002531","name":"CMT64/61 cell","definition":"[]","term_type":"cell line"}]}